Vow ASA: Gunnar Pedersen to assume CEO role on 19 May 2025
Oslo, 7 May 2025 - With reference to the announcement made on 5 February 2025 regarding the appointment of Gunnar Pedersen as the new Chief Executive Officer of Vow ASA, the company is pleased to confirm that Mr. Pedersen will assume the role earlier than initially scheduled.
OpenAI To Slash Microsoft Revenue Share By 2030: Report - Microsoft ( NASDAQ:MSFT ) , Oracle ( NYSE:ORCL )
OpenAI reportedly plans to cut the share of revenue it pays to Microsoft Corporation MSFT by at least half by the end of the decade. What Happened: OpenAI has informed investors that it will reduce the percentage of revenue it shares with Microsoft, its largest backer, reported Reuters on Tuesday ...
Bitcoin gains as crypto investors bet on positive US-China trade talks
The rally followed news that the US treasury secretary and trade representative will meet with the Chinese government in Switzerland this week.
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.
Coinbase Stock Trades Higher After-Hours Amid Partnership With League Of Legends, Valorant Developer Riot Games - Tencent Holdings ( OTC:TCEHY ) , Coinbase Global ( NASDAQ:COIN )
Coinbase Global Inc. COIN has teamed up with leading video game developer Riot Games to become the exclusive cryptocurrency exchange for Valorant and League of Legends esports global events, according to a Tuesday announcement.
BIGC Launches Ticket Sales for YE ( Kanye West ) 's YE LIVE IN KOREA, PRESENTED BY COUPANG PLAY
SEOUL, South Korea, May 07, 2025 ( GLOBE NEWSWIRE ) -- Global enter-tech platform BIGC has opened ticket sales for YE ( Kanye West ) 's concert in Korea, YE LIVE IN KOREA, PRESENTED BY COUPANG PLAY.
Late-breaking exploratory data highlights the impact of IQIRVO® ( elafibranor ) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis
PARIS, FRANCE, 7 May 2025 Today, Ipsen ( Euronext: IPN. ADR: IPSEY ) announced new data from two late-breaking presentations on IQIRVO® ( elafibranor ) during the European Association for the Study of the Liver congress.
